Testing for multiple T1D-related autoantibodies, such as anti-GAD65, anti-insulin, anti-IA2, and anti-ZnT8 antibodies, is important since these are increased in 85–90% of patients with T1D. This evidence concerns the gene PTPRN and type 1 diabetes mellitus.